Bayer MaterialScience lifts force majeure in the USA for most products

Leverkusen/Baytown – Bayer MaterialScience has lifted force majeure for most of the products manufactured at its facility in Baytown, Texas, United States. Effective today, there are no longer any restrictions on the company’s ability to supply diphenylmethane diisocyanate (MDI) and isophorone diisocyanate (IPDI) in drums. The company had already lifted force majeure at the beginning of October for Makrolon® polycarbonate and polycarbonate blends, and for toluene diisocyanate (TDI) and some inorganic basic chemicals. Force majeure was also lifted on November 1 for polyether polyol (PET) products manufactured in North America, and some isocyanate products, but remains in effect for liquid polyester coatings raw materials.

Force majeure had been declared for these and other products in September 2008, after hurricanes Ike and Gustav had inflicted extensive damage in the Houston, Texas, region, which also affected some suppliers’ facilities in Texas and Louisiana.

About Bayer MaterialScience:
With 2007 sales of EUR 10.4 billion, Bayer MaterialScience is among the world’s largest polymer companies. Business activities are focused on the manufacture of high-tech polymer materials and the development of innovative solutions for products used in many areas of daily life. The main segments served are the automotive, electrical and electronics, construction, and sports and leisure industries. At the end of 2007, Bayer MaterialScience had 30 production sites and employed approximately 15,400 people around the globe. Bayer MaterialScience is a Bayer Group company.

Find more information at www.bayermaterialscience.com

Hotline for readers’ inquiries: Fax: +49 221 9902-160


Forward-Looking Statements
This release may contain forward-looking statements based on current assumptions and forecasts made by Bayer Group or subgroup management. Various known and unknown risks, uncertainties and other factors could lead to material differences between the actual future results, financial situation, development or performance of the company and the estimates given here. These factors include those discussed in Bayer’s public reports which are available on the Bayer website at www.bayer.com. The company assumes no liability whatsoever to update these forward-looking statements or to conform them to future events or developments.